Dexcel Pharma Technologies Ltd.

Pharma

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Orange Book Patents

Across 3 drugs with upcoming expirations

Activity

Key Events

Oct 20, 2020FDANexium — ESOMEPRAZOLE MAGNESIUM

Nov 20, 2018FDAPeridex — READYPREP CHG

Jul 5, 2017FDAPrilosec — OMEPRAZOLE

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Patent Expirations

5 patent groups across drugs · Source: FDA Orange Book

DrugExpires

PeridexApr 25, 2026 PeridexOct 2, 2027 PrilosecJan 31, 2030 NexiumDec 8, 2036 PrilosecDec 8, 2036

Regulatory

Regulatory Timeline

19861 event

FDAAug 13

Peridex — PERIDEX

Application NDA019028 (NDA)

19871 event

FDAMar 27

Peridex — CHLORHEXIDINE GLUCONATE

Application NDA019490 (NDA)

19881 event

FDADec 2

Peridex — PHARMASEAL SCRUB CARE

Application NDA019793 (NDA)

19891 event

FDAMar 31

Peridex — BIOSCRUB

Application NDA019822 (NDA)

19951 event

FDAOct 5

Prilosec — PRILOSEC

Application NDA019810 (NDA)

19971 event

FDASep 11

Peridex — CHLORHEXIDINE GLUCONATE

Application NDA020111 (NDA)

19981 event

FDAMay 15

Peridex — PERIOCHIP

Application NDA020774 (NDA)

20011 event

FDAFeb 20

Nexium — NEXIUM

Application NDA021153 (NDA)

20031 event

FDAJun 20

Prilosec — PRILOSEC OTC

Application NDA021229 (NDA)

20052 events

FDAApr 25

Peridex — CHLORHEXIDINE GLUCONATE

Application NDA021669 (NDA)

FDAMar 31

Nexium — NEXIUM IV

Application NDA021689 (NDA)

20071 event

FDADec 4

Prilosec — OMEPRAZOLE

Application NDA022032 (NDA)

20082 events

FDAMar 20

Prilosec — PRILOSEC

Application NDA022056 (NDA)

FDAFeb 27

Nexium — NEXIUM

Application NDA022101 (NDA)

20111 event

FDADec 15

Nexium — NEXIUM

Application NDA021957 (NDA)

20141 event

FDAMar 28

Nexium — NEXIUM 24HR

Application NDA204655 (NDA)

20151 event

FDANov 23

Nexium — NEXIUM 24HR

Application NDA207920 (NDA)

20171 event

FDAJul 5

Prilosec — OMEPRAZOLE

Application NDA209400 (NDA)

20181 event

FDANov 20

Peridex — READYPREP CHG

Application NDA207964 (NDA)

20201 event

FDAOct 20

Nexium — ESOMEPRAZOLE MAGNESIUM

Application NDA214278 (NDA)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)